Nasdaq Stockholm AB: New equity right for trading, Diagonal Bio AB TO1

At the request of Diagonal Bio AB, Diagonal Bio AB equity rights will be traded
on First North Growth Market as from May 17, 2024. 



Security name: Diagonal Bio AB TO1
-----------------------------------
Short name:   DIABIO TO1     
-----------------------------------
ISIN code:   SE0021921517    
-----------------------------------
Orderbook ID:  336517       
-----------------------------------





Terms: The exercise price for TO 1 shall amount to seventy (70) percent of the 
     average volume-weighted price of the share according to the official  
     price statistics of the Nasdaq First North Growth Market during a   
     period of twenty (20) trading days ending two (2) banking days before 
     the start of the exercise period and the exercise price will be    
     determined within the range of SEK 0.05-0.12 per new share. The    
     exercise price must be rounded to the nearest whole öre.        
--------------------------------------------------------------------------------
   - 1 option rights gives the right to subscribe for            
    1 new share in Diagonal Bio AB                     
--------------------------------------------------------------------------------
Subscr 12th of September 2024 - 26th of September 2024             
iption                                     
 perio                                     
d:                                       
--------------------------------------------------------------------------------
Last  24th of September 2024.                         
 tradi                                     
ng                                       
 day:                                      
--------------------------------------------------------------------------------



This information is distributed at the request of the Certified Adviser, Svensk
Kapitalmarknadsgranskning AB (SKMG). 

For further information, please call SKMG on [phone].